ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework by Oleg Timofeev, Philippe Giron, Steffen Lawo, Martin Pichler, Maxim Noeparast

Get full text

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib by Carolien Eggermont, Gustavo J. Gutierrez, Jacques De Grève, Philippe Giron

Get full text

Structure–Activity Relationship (SAR) Study of Spautin-1 to Entail the Discovery of Novel NEK4 Inhibitors by Mathias Elsocht, Philippe Giron, Laila Maes, Wim Versées, Gustavo J. Gutierrez, Jacques De Grève, Steven Ballet

Get full text

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer by Carolien Eggermont, Philippe Giron, Maxim Noeparast, Hugo Vandenplas, Pedro Aza-Blanc, Gustavo J. Gutierrez, Jacques De Grève

Get full text

Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector by Alfiah Noor, Gudrun Walser, Matthijs Wesseling, Philippe Giron, Albert-Menno Laffra, Fatima Haddouchi, Jacques De Grève, Peter Kronenberger

Get full text

Peripheral precocious puberty in Li–Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumors by Sofie Ryckx, Jean De Schepper, Philippe Giron, Ken Maes, Freya Vaeyens, Kaat Wilgenhof, Pierre Lefesvre, Caroline Ernst, Kim Vanderlinden, Daniel Klink, Frederik Hes, Jesse Vanbesien, Inge Gies, Willem Staels

Get full text

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis by Cabirou Mounchili Shintouo, Robert Adamu Shey, Derrick Neba Nebangwa, Kevin K. Esoh, Nkemngo Francis Nongley, Joel Ebai Nguve, Philippe Giron, Léon Mutesa, Luc Vanhamme, Jacob Souopgui, Stephen Mbigha Ghogomu, Rose Njemini

Get full text